Bausch + Lomb Corporation (BLCO) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Bausch + Lomb has acquired Elios Vision to enhance its glaucoma treatment capabilities with the innovative ELIOS procedure, which is minimally invasive and uses an excimer laser. This strategic move aims to integrate glaucoma treatment with cataract surgery, potentially transforming treatment standards for millions of patients globally.
For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.
